"With nearly 100 years of experience, Vance Thompson Vision is committed to using the most advanced technology and sets standards across the world."

During the past decade, Vance Thompson Vision conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 14 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 11 clinical trials were completed. i.e. 44% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vance Thompson Vision" #1 sponsor was "Vance Thompson Vision" with 7 trials, followed by "Glaukos Corporation" with 6 trials sponsored, "Abbott Medical Optics" with 3 trials sponsored, "AcuFocus, Inc." with 3 trials sponsored and "RxSight, Inc." with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vance Thompson Vision" #1 collaborator was "Alcon Research" with 3 trials as a collaborator, "Cathleen McCabe, MD" with 1 trials as a collaborator, "Harvey Reiser, MD" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Ocular Therapeutix, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Vance Thompson Vision" are "Cataract" (13 trials), "Presbyopia" (7 trials), "Myopia" (5 trials), "Aphakia" (4 trials) and "Astigmatism" (3 trials). Many other conditions were trialed in "Vance Thompson Vision" in a lesser frequency.

Most popular intervention types in "Vance Thompson Vision" are "Device" (33 trials), "Drug" (17 trials), "Procedure" (5 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control Group" (2 trials), "Control IOL" (2 trials), "KXL System" (2 trials), "Light Adjustable lens (LAL) and Light Delivery Device (LDD)" (2 trials) and "TTHX1114(NM141)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vance Thompson Vision" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Vance Thompson Vision". 1 are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Vance Thompson Vision, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Vance Thompson Vision, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 25 trials that are defined as “Not Applicable".